Locations

SIU Medicine Pediatric Genetics | St. John's Children's Hosptial

415 N. 9th St. Springfield, IL 62701 2nd Floor, Suite 2W106
Mon - Fri: 8:00 am-4:30 pm
Locations

SIU Medicine Pediatric Genetics | St. John's Children's Hosptial

415 N. 9th St. Springfield, IL 62701 2nd Floor, Suite 2W106
Mon - Fri: 8:00 am-4:30 pm
News

Restoring smiles, transforming lives through cleft lip and palate care

A cleft lip or cleft palate, also known as an orofacial cleft, is one of the most common birth defects or malformations. It occurs when a baby’s lip or mouth doesn’t form as expected.
Trial
Psychiatry

ITI-007-601: A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Lumateperone in the Treatment of Irritability Associated with Autism Spectrum Disorder in Pediatric Patients 5 to 17 Years of Age

Active recruiting
The primary objective is to evaluate the efficacy of high and low doses of lumateperone vs placebo for the treatment of irritability associated with autism spectrum disorder (ASD) in pediatric patients as measured by the change from baseline to end of Week 6 in the ABC Irritability (ABC-I) subscale score.
Trial
Neurology

Xenon XPF-010-303: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures

Active recruiting
The primary objective is to assess the effect of XEN1101 versus placebo on reducing PGTCS frequency in subjects with PGTCS.
Trial
Neurology

Xenon XPF-010-302: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Focal-Onset Seizures

Active recruiting
The primary objective of this study is to assess the effect of XEN1101 versus placebo on reducing focal seizure frequency.
Trial
Neurology

UCB EP0162: A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Outpatient, Parallel-Group Study to Assess the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older with Stereotypical Prolonged Seizures

Active recruiting
The purpose of this study is to compare the success of a single admnistration of Staccato alprazolam compared with placebo in rapidly terminating a seizure episode within 90seconds after IMP administration.
Trial
Trial
Neurology

ADCS Benfo: A Seamless Phase 2A-Phase 2B Randomized Double-Blind Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients with Early Alzheimer’s Disease (BenfoTeam)

Active recruiting
The purpose of this study is to learn more about the safety, effectiveness and tolerability of the study drug called Benfotiamine, to determine whether it delays or slows the progression of the symptoms of early Alzheimer’s disease.
Subscribe to Patient